CXCL10 and central nervous system cancer: Compared to gliomas with wtIDH1/2, IDH-mutated gliomas show small numbers of tumor-infiltrating CD4+ and CD8+ T cells [140] and a low expression of cytotoxic T-lymphocyte–associated genes and IFN-γ–inducible chemokines, including CXCL10 [141].